:max_bytes(150000):strip_icc():format(jpeg)/Cholesterol-Medication-Is-Being-Recalled-Nationwide-83ca987d78b84b87a857493c45fe338b.jpg)
- At least 141,984 bottles of cholesterol medication are being recalled nationwide.
- The prescription impacted is Atorvastatin Calcium tablets sold in 90-count, 500-count and 1000-count packages.
- Contact your healthcare provider or pharmacy for a potential refund or replacement.
The U.S. Food and Drug Administration announced a recall on prescription statin medication sold nationwide. This is due to “failed dissolution specifications.”
The drugs impacted by this recall are Atorvastatin Calcium tablets manufactured by Ascend Laboratories, LLC. At least 141,984 bottles of the product are affected. Below is the list of cholesterol medication being recalled, including lot codes and expiration dates that can be found on the bottles or packaging:
Product Description
Pill Count
Lot Numbers
Expiration Dates
Atorvastatin Calcium Tablets USP, 10 mg
90-count; 500-count 1000-count
25141249; 24144938; 24144868; 24144867; 24144458; 24143994; 24142987; 24143316
Feb. 2027; Nov. 2026; Sept. 2026; July 2026
Atorvastatin Calcium Tablets USP, 40 mg, Rx Only
90-count; 500-count 1000-count
25140933; 25140477; 24144254; 24144163; 24143995
Feb. 2027; Dec. 2026; Oct. 2026; Sept. 2026
Atorvastatin Calcium Tablets USP, 20 mg, Rx Only
90-count; 500-count 1000-count
25140150; 25140173; 25140172; 24144720; 24144798; 24144692; 24143755; 24143913; 24143754; 24143047; 24142936
Dec. 2026, Nov. 2026; Oct. 2026; Aug. 2026; July 2026; June 2026
Atorvastatin Calcium Tablets USP, 80 mg, Rx Only
90-count, 500-count
25140249; 25140247; 24144999; 24144942; 24144845; 24144713; 24144652; 24143898; 24143412; 24143582
Dec. 2026; Nov. 2026; Oct. 2026; Aug. 2026
Check your medication, and if it matches any of the above recall information, contact your healthcare provider or pharmacy for a replacement or potential refund. This recall was just classified as a Class II, meaning that the recalled tablets may lead to minor, temporary health problems.
For questions about this recall, contact the FDA at 1-888-INFO-FDA (1-888-463-6332).
